FAO Nutrition Meetings Report Series No. 48A WHO/FOOD ADD/70.39 TOXICOLOGICAL EVALUATION OF SOME EXTRACTION SOLVENTS AND CERTAIN OTHER SUBSTANCES The content of this document is the result of the deliberations of the Joint FAO/WHO Expert Committee on Food Additives which met in Geneva, 24 June -2 July 19701 Food and Agriculture Organization of the United Nations World Health Organization 1 Fourteenth report of the Joint FAO/WHO Expert Committee on Food Additives, FAO Nutrition Meetings Report Series in press; Wld Hlth Org. techn. Rep. Ser., in press. SACCHARIN The previous assessment was based on work performed in the 1950s and a large number of new studies on saccharin alone are being undertaken or are presently in progress. The results of further experiments using mixtures of cyclamate and saccharin have now become available for evaluation. These should be evaluated when the full data have become available. Comments Calcium and sodium cyclamate have been evaluated previously by the Eleventh Joint FAO/WHO Expert Committee on Food Additives in 1967. The additional data now reviewed have thrown little further light on the exact mechanism of the laxative effect or on the changes observed in the cellular and subcellular structures of the gastro-intestinal tract. These two problems have been left unanswered at the time of the first review. There is now good evidence that a proportion of the human population is able to convert cyclamate to cyclohexylamine and it is likely that this conversion takes place as a result of the activity of the microbial flora of the gut. Recent work has raised the problem of mutagenicity of cyclamate as observed under various conditions of testing but it is not possible to interpret these findings in terms of human risk when taken in isolation. There is some doubt whether the observed chromosomal changes are specific to cyclamate. More serious are the findings reported in relation to bladder carcinoma found after feeding very high doses of cyclamate/saccharin mixtures and the more recent reports of the production of bladder carcinoma following feeding of cyclamate alone. it is difficult to extrapolate these findings to man on the data available. Nonetheless, the new information together with the previously available evidence on toxicity as well as the discovery of the metabolic fate of cyclamate and the toxicity of cyclohexylamine, counsels prudence in the future use of cyclamates in food and drink. Cyclohexylamine, a known metabolite of cyclamate in some animals and man, is itself further metabolized but not all of these metabolites have been identified. One long-term study has resulted in the production of a single bladder tumour but the number of survivors was too small to allow adequate evaluation. Cyclohexylamine may have been involved in the appearance of bladder carcinoma following ingestion of large doses of cyclamate and cyclamate/saccharin mixture by rats. Evaluation Because of the possible carcinogenic potential of cyclamate in the rat, an ADI for this compound cannot be established at the present time, and therefore the previously established temporary ADI is now withdrawn. The use of cyclamate in the management of diabetes and gross obesity was beyond the purview of food additive consideration. REFERENCES Abbott Laboratories (1967) Unpublished report submitted to WHO Abbott Laboratories (1968) Unpublished report Submitted to WHO Abbott Laboratories (1970) Unpublished report submitted to WHO Bajusz, E. (1969) Nature, 223, 406 Batterman, R. C. (1966) Unpublished report to Abbott Laboratories, 326602 & 326723 Bein, H. J. et 1. (1967) Unpublished report submitted to WHO Blocktüs, L. E. et al. (1968) Unpublished report to Abbott Laboratories, 316811 Bryan, G. T. & Ertuürk, E. (1970) Science, 117 Buchel, L. & Guyonneau, M. (1963) Thérapie, 18, 953 Burbank, F. & Fraugment, J. F. (1970) Nature, in press Carswell, T. S. & Morrill, H. L. (1937) Ind. Eng. Chem., 29, 1247 Chung, C. W. (1969) FDA report to NAS-NRC Classen, H. G., Marquardt, P. & Späth, M. (1968) Arzneimittel-Forsch, 18, 590 Davis, T. R. A., Adler, N. & Opsall, J. C. (1969) Toxicol. appl: Pharmacol., 15, 10 Dick, C. & Brava, C. G. (1970) Environ. Mutagen. Soc., 1st Ann. Meeting, Abstr. 35 Dubois, K. P. & Kinoshita, F. (1968) Unpublished report to Abbott Laboratories, 316807 Elliott, T. H. Lee, N. Y. & Tao, R. C. C. (1968) Biochemistry, 109; 11P-12P FAO/WHO (1967) FAO Nutrition Meetings Report Series 44A; WHO/Food Add./68.33 Fels Research Laboratory (1969) FDA Report to NAS-NRC Feingold, B. F. (1968) Ann. Allergy, 26, 309 Ferrando, R., Hachet, B. & Boivin, M. R. (1968) Bull. Acad. Med., 152, 36 Flinn, F. B. (1937) Unpublished report from FDA Food and Drug Research Laboratories, Inc. (1969) Unpublished report to Abbott Laboratories Food and Drug Research Laboratories, Inc. (1970) Unpublished report to Abbott Laboratories Foster D. Snell, Inc. (1968) Food Cosmet. Toxicol., 6, 313 Freese, H., Jencke, T. S. & Rubenkoenig, H. (1964) Unpublished report to Abbott Laboratories, 326401, 326723 Fritz H. & Hess, R (1968) Experiential (Zasel), 24, 1140 Ghiani, P. & Accame, R. (1969) Unpublished report submitted to WHO Goldberg, L. et al.(1969) Soc. Tox. 8th Ann. Meeting, Abst. 107 Goldberg, L. et al. (1969) Toxicol. appl. Pharmacol., 14, 6541 (?) Göttinger, E. et al. (1968)Wien. Kl. Wschr., 80, 329 Hellauer, H. (1968) 5th Int. Conf. Hyg. Prev. Med., Rome 1968 Huntingdon Research Centre (1967) Unpublished report submitted to WHO Industrial Bio-test Lab. Inc. (1967) Unpublished report to Abbott Laboratories Industrial Bio-test Lab. Inc. (1968) Unpublished report to Abbott Laboratories Industrial Bio-test Lab. Inc. (1969a) Unpublished report to Abbott Laboratories Industrial Bio-test Lab. Inc. (1969b) Unpublished report to Abbott Laboratories Jackson, G. (1968) Unpublished report to Abbott Laboratories, 316812 Kennedy P. Arnold (1967) Unpublished report to Abbott Laboratories, 316748 Klotsche, C. (1969) Arzneimittel-Forsch, 19, 925 Lamberg, S. I.(1967) J. Amer. med. Ass., 201, 747 Lee, I. P. & Dixon, R. L. (1969) Toxicol. appl. Pharmacol., 14, Abst. p. 654 Legator, M.S. et al. (1969) Science, 165, 1139 Lethco, E., Wallace, W. & Braunberg, R. (1969) FDA report to NAS-NRC Lomonova, G. V. (1963) Gig. Trüda Prof. Zabol., 7, 51 Lorke, D. (1969) Arzneimittel-Forsch, 19, 923 Loser, E. (1970) Unpublished report submitted to WHO Malletto, F. S. & von Haam, E. (1952) Arch. ind. Hyg. Occ. Med.,5, 311 Mauer, R. E & Szymauski, E.T. (1968) Unpublished report to Abbott Laboratories, 316806 Mollet, M. (1966) Unpublished report to Abbott Laboratories, 316611-4 Olson, W. H. (1955) Unpublished report to Abbott Laboratories Oser, B. L. (1968) Unpublished report to Abbott Laboratories, 316804 Oser, B. L. (1969) Unpublished report submitted to WHO and to Abbott Laboratories, 316901 Oser, B, L., Carson, S. & Vogin, E. E. (1968) Nature, 220, 179 Palmer, K. (1968) 7th Conf. Manual Cytol. & Somatic Cell Genetics Pitkin, R. M., Reynolds, W. A. & Filer, J. (1969) Proc. Soc. exp. Biol. Med., 132, 993 Pitkin, R. M., Reynolds, W. A. & Filer, L. J. (1970) JAMA, in press Pliss, G. B. (1958) Vop. Onkol., 4, 659 Price, J. M. et al. (1969) BIBRA Bull., 8(9), 456 Prosky, L. & 0'Dell, R. G. (1970) Fed. Abstr., 29, 1797 Radding, R. S. (1967) Unpublished report to Abbott Laboratories Ltd., 326702, 326723 Renwick, A. G. & Williams, R. T. (1969) Proc. Bioch. Soc., 114, Abst. 44 Roe, F. J. C., Levy, L. S. & Carter, R. L. (1970) Food Cosm. Tox. 8, 135 Rosenblum, I. (1968) Soc. Toxicol. 7th Ann. Meeting, Abst. 11 Rosenblum, I. & Rosenblum G. (1968) Toxicol. appl. Pharmacol., 12, 260 and 13, 339 Rudali, G., Coezy, E. & Muranyi-Kovacs, I. (1969) C. R. Acad. Sci., Paris, 269, 1910 Sax, K. & Sax. H. J. (1968) Japan J. Genetics, 43, 89 Sonders, R. C. (1969) Am. Soc. Pharm, Exp. Ther., August 1969 Sonders, R. C. & Wiegand, R. G. (1968) Soc. tox., 7th Ann. Meeting, Abst. 16 Sonders, R. G. Netwal, J. C. & Wiegand, R. G. (1970) Unpublished report to Abbott Laboratories Stern, S. B. (1967) Unpublished report to Abbott Laboratories, 326706-8, 326723 Stoltz, D. R. et al. (1970) Science, 167, 1501 Stone, D., Lamson, E. & Chang, Y. S. (1969) Science, 164, 568 Tanaka, R. (1964a) Jap. J. Publ. Health, 11, 909 Tanaka, R. (1964b) J. Iwate Med. Ass., 16, 330 Tremolières (1964) Unpublished report to Abbott Laboratories, 316401 Unilever Research Laboratories (1970) Unpublished report submitted to WHO US Food and Drug Admin. (1969) Unpublished report submitted to WHO US Food and Drug Admin. (1969) Report to NAS-NRC Verrett, M. J. (1969) FDA report to NAS-NRC Wagner, J. G. (1969) The Sciences, 9, 20 Watrons, R. M. & Schulz, H. N. (1950) Ind. Med. Surg., 19, 317 Wechsler, A. S., Epstein, S. E. & Click, G. (1969) J. Pharmac. exp. Ther., 170(1), 62 Weinberg, M. S. & Harrington, E. M. (1968) Toxicol. appl. Pharmacol., 12, 290 Wills, J. H. et al. (1968) Toxicol. appl. Pharmacol., 12, 292 Woodward Research Lab. (1963) Unpublished report to Abbott Laboratories Woodward Research Lab. (1964) Unpublished report to Abbott Laboratories Wortman, B., Locke, R. K. & Schrogie, J. J. (1968) Soc. Toxic 8th Ann. Meeting, Abst. 108 Yamamura, H. I. & Dixon, R. L. (1968) Soc. Toxic. 7th Ann. Meeting, Abst. 12 Yamamura, H. I., Lee, I. P. & Dixon, R. L. (1968) J. Pharm. Sci., 571, 1132 Zollner, N. & Pieper, M. (1970) Unpublished report submitted to WHO Zollner, N. & Schuelle, K. (1969) Arzneimittel-Forsch, 19, 913
See Also: Toxicological Abbreviations Saccharin (FAO Nutrition Meetings Report Series 44a) Saccharin (WHO Food Additives Series 17) SACCHARIN (JECFA Evaluation) Saccharin (IARC Summary & Evaluation, Supplement7, 1987) Saccharin (IARC Summary & Evaluation, Volume 22, 1980)